|
End-of-day quote
Shenzhen S.E.
2026-08-14
|
5-day change | 1st Jan Change | ||
| 11.61 CNY | -0.43% |
|
+4.22% | -4.44% |
| May. 22 | Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug | MT |
| May. 19 | China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug | MT |
| Market Cap | 3.89B 576M 498M 468M 426M 800M 55.12B 813M 5.48B 2.14B 27.6B 2.16B 2.12B 91.73B | P/E 2024 |
79.5x | P/E 2025 | -63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 4.16B 617M 533M 501M 456M 857M 59.04B 871M 5.87B 2.3B 29.56B 2.32B 2.27B 98.25B | EV / Sales 2024 |
2.95x | EV / Sales 2025 | 3.69x |
| Free-Float |
44% | Yield 2024 |
1.57% | Yield 2025 | - |
| 1 day | -0.43% | ||
| 1 week | +4.22% | ||
| Current month | +12.17% | ||
| 1 month | +5.16% | ||
| 3 months | -7.12% | ||
| 6 months | -25.62% | ||
| Current year | -4.44% |
| 1 week | 11.11 |  | 11.88 |
| 1 month | 10 | | 12.11 |
| Current year | 9.02 | | 18.96 |
| 1 year | 9.02 | | 18.96 |
| 3 years | 6.81 | | 19.56 |
| 5 years | 6.81 | | 22.25 |
| 10 years | 6.81 | | 22.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jie Liu
CEO | Chief Executive Officer | 50 | 2018-10-20 |
Shen Hua Shi
DFI | Director of Finance/CFO | 63 | 2011-04-15 |
Chun Yan You
PRN | Corporate Officer/Principal | 50 | 2018-01-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Xin Min Chen
CHM | Chairman | 60 | 2018-10-20 |
Zhi Jun Hua
CHM | Chairman | 57 | 2011-04-15 |
Jie Liu
BRD | Director/Board Member | 50 | 2020-03-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.43% | +4.22% | -18.70% | -12.11% | 576M | |
| -2.25% | -0.47% | +72.43% | +119.36% | 1,052B | |
| -0.66% | +0.43% | +49.01% | +50.11% | 627B | |
| -0.54% | +1.39% | +21.88% | +63.83% | 441B | |
| -1.99% | -3.32% | +41.98% | +34.08% | 349B | |
| -1.05% | -2.81% | +24.22% | +34.67% | 287B | |
| -2.12% | -3.67% | -1.09% | +3.11% | 241B | |
| -0.63% | +1.04% | +43.03% | +59.10% | 224B | |
| -1.19% | -3.41% | -9.18% | -52.41% | 202B | |
| +0.16% | +3.87% | +16.25% | +73.27% | 172B | |
| Average | -0.64% | +0.49% | +23.98% | +37.30% | 359.58B | |
| Weighted average by Cap. | -0.09% | +0.32% | +41.31% | +62.01% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.18B 175M 151M 142M 129M 243M 16.76B 247M 1.67B 652M 8.39B 658M 644M 27.9B | 1.18B 174M 151M 142M 129M 242M 16.68B 246M 1.66B 649M 8.35B 655M 641M 27.75B |
| Net income | 39.88M 5.91M 5.11M 4.8M 4.36M 8.21M 565M 8.34M 56.23M 21.99M 283M 22.2M 21.72M 941M | -63.47M -9.41M -8.13M -7.64M -6.95M -13.06M -900M -13.27M -89.49M -34.99M -451M -35.33M -34.57M -1.5B |
| Net Debt | 294M 43.58M 37.64M 35.37M 32.17M 60.48M 4.17B 61.48M 414M 162M 2.09B 164M 160M 6.94B | 276M 40.94M 35.36M 33.22M 30.22M 56.81M 3.91B 57.74M 389M 152M 1.96B 154M 150M 6.51B |
Employees
1,655
Sector
Pharmaceuticals
Calendar
Aug. 20
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | CN¥11.61 | -0.43% | 9,323,851 |
| 26-08-13 | CN¥11.66 | +0.52% | 10,944,760 |
| 26-08-12 | CN¥11.60 | +0.96% | 7,810,150 |
| 26-08-11 | CN¥11.49 | 0.00% | 12,192,856 |
| 26-08-10 | CN¥11.49 | +3.14% | 14,031,271 |
- Stock Market
- Stocks
- 002923 Stock
Select your edition
All financial news and data tailored to specific country editions
